PYC Therapeutics Limited (ASX:PYC)
Australia · Delayed Price · Currency is AUD 2.400
+0.155 (6.90%)
Sep 17, 2026, 4:10 PM AEST
PYC Therapeutics Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, PYC Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $3.94. The average 1-year stock price forecast is 64.17% higher than the current stock price, while the lowest is $2.84 (+18.33%) and the highest is $5.00 (+108.33%).
Price Target: $3.94 (+64.17%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for PYC Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bell Potter | Bell Potter | Buy Maintains $2.30 → $3.00 | Buy | Maintains | $2.30 → $3.00 | +25.00% | Sep 14, 2026 |
Unknown Analyst Ord Minnett No rating | Ord Minnett | Buy Maintains $4.10 | Buy | Maintains | $4.10 | +70.83% | Sep 4, 2026 |
| Bloom Burton | Bloom Burton | Buy Maintains $5.00 | Buy | Maintains | $5.00 | +108.33% | Aug 6, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $2.84 | Buy | Maintains | $2.84 | +18.33% | Jun 6, 2026 |
Financial Forecast
Revenue This Year
n/a
from 25.99M
Decreased by -100.00%
Revenue Next Year
n/a
EPS This Year
-0.08
from -0.06
EPS Next Year
-0.09
from -0.08
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.